Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,033 | -67,316 | -53,518 | -18,068 | -125,712 |
| Depreciation Amortization | 263 | 198 | 132 | 66 | 262 |
| Accounts payable and accrued liabilities | -2,931 | -3,628 | -478 | 2,887 | 3,799 |
| Other Working Capital | -12,673 | -9,806 | -6,682 | 3,765 | 3,058 |
| Other Operating Activity | 40,277 | 38,901 | 33,320 | 3,672 | 62,093 |
| Operating Cash Flow | $-55,097 | $-41,651 | $-27,226 | $-7,678 | $-56,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,233 | -3,715 | N/A | N/A | N/A |
| PPE Investments | -132 | -23 | N/A | N/A | -7 |
| Net Acquisitions | 250 | 250 | 250 | 250 | 2,150 |
| Investing Cash Flow | $-8,115 | $-3,488 | $250 | $250 | $2,143 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 84,938 | 81,719 | 81,719 | 6,273 | 57,584 |
| Dividend Paid | N/A | N/A | N/A | N/A | -157 |
| Other Financing Activity | -6,862 | -5,835 | -5,424 | -6 | -3,010 |
| Financing Cash Flow | $78,076 | $75,884 | $76,295 | $6,267 | $54,417 |
| Beginning Cash Position | 1,761 | 1,761 | 1,761 | 1,761 | 1,701 |
| End Cash Position | 16,625 | 32,506 | 51,080 | 600 | 1,761 |
| Net Cash Flow | $14,864 | $30,745 | $49,319 | $-1,161 | $60 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,097 | -41,651 | -27,226 | -7,678 | -56,500 |
| Capital Expenditure | -164 | -23 | N/A | N/A | -7 |
| Free Cash Flow | -55,261 | -41,674 | -27,226 | -7,678 | -56,507 |